Literature DB >> 22669020

Autosomal recessive hypercholesterolaemia in a Morrocan family due to a mutation of the G266C LDL receptor.

Siham El Aziz1, Asma Chadli, Hassan El Ghomari, Ahmed Farouqi.   

Abstract

Familial hypercholesterolaemia (FH) is quite common genetic disorder resulting in high low-density lipoprotein (LDL) cholesterol levels, but homozygous FH is rare. The authors describe a Moroccan family where a 24-year-old man and his 13-year-old brother, born from a consanguineous union, showed characteristics of FH with large tendon, tuberous and planar xanthomas. They had already five deaths in the sibship before the age of 15 years. Blood analysis found high LDL cholesterol levels. Arterial assessment showed diffuse atherosis. Genetic study found that patients are homozygous for the mutation of G266C LDL receptor. Treatment with high doses of statins and ezetimibe was introduced reducing cholesterol up to 70%. Large xanthomas were removed surgically. The G266C mutation has been previously identified in Morocco. Early identification and adequate treatment of individuals with hypercholesterolaemia and their relatives are essential for prevention of early death in these populations.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22669020      PMCID: PMC3369364          DOI: 10.1136/bcr.02.2012.5717

Source DB:  PubMed          Journal:  BMJ Case Rep        ISSN: 1757-790X


  26 in total

1.  Familial hypercholesterolemia associated with severe hypoalphalipoproteinemia in a Moroccan family.

Authors:  Karima Ait Chihab; Rachif Chater; Ana Cenarro; Anass Kettani; Sergio Castillo; Mohamed Loutfi; Josep Ribalta; Ahmed Adlouni; Miguel Pocovi; Mariame El Messal
Journal:  J Genet       Date:  2007-08       Impact factor: 1.166

2.  Statin treatment in children with familial hypercholesterolemia: the younger, the better.

Authors:  Jessica Rodenburg; Maud N Vissers; Albert Wiegman; A S Paul van Trotsenburg; Anouk van der Graaf; Eric de Groot; Frits A Wijburg; John J P Kastelein; Barbara A Hutten
Journal:  Circulation       Date:  2007-07-30       Impact factor: 29.690

3.  Familial hypercholesterolaemia: summary of NICE guidance.

Authors:  Anthony S Wierzbicki; Steve E Humphries; Rubin Minhas
Journal:  BMJ       Date:  2008-08-27

4.  Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing.

Authors:  Brian W McCrindle; Elaine M Urbina; Barbara A Dennison; Marc S Jacobson; Julia Steinberger; Albert P Rocchini; Laura L Hayman; Stephen R Daniels
Journal:  Circulation       Date:  2007-03-21       Impact factor: 29.690

Review 5.  Genetic heterogeneity of autosomal dominant hypercholesterolemia.

Authors:  M Varret; M Abifadel; J-P Rabès; C Boileau
Journal:  Clin Genet       Date:  2007-11-16       Impact factor: 4.438

Review 6.  Familial hypercholesterolemia: current treatment and advances in management.

Authors:  Roeland Huijgen; Maud N Vissers; Joep C Defesche; Peter J Lansberg; John J P Kastelein; Barbara A Hutten
Journal:  Expert Rev Cardiovasc Ther       Date:  2008-04

7.  Efficacy and safety of coadministration of ezetimibe and simvastatin in adolescents with heterozygous familial hypercholesterolemia.

Authors:  Anouk van der Graaf; Cynthia Cuffie-Jackson; Maud N Vissers; Mieke D Trip; Claude Gagné; Genming Shi; Enrico Veltri; Hans J Avis; John J P Kastelein
Journal:  J Am Coll Cardiol       Date:  2008-10-21       Impact factor: 24.094

Review 8.  Primary and secondary disorders of lipid metabolism in pediatrics.

Authors:  Peter O Kwiterovich
Journal:  Pediatr Endocrinol Rev       Date:  2008-02

9.  Update and analysis of the University College London low density lipoprotein receptor familial hypercholesterolemia database.

Authors:  S E A Leigh; A H Foster; R A Whittall; C S Hubbart; S E Humphries
Journal:  Ann Hum Genet       Date:  2008-03-05       Impact factor: 1.670

10.  Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study.

Authors:  Andrew Neil; Jackie Cooper; John Betteridge; Nigel Capps; Ian McDowell; Paul Durrington; Mary Seed; Steve E Humphries
Journal:  Eur Heart J       Date:  2008-10-07       Impact factor: 29.983

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.